Venclexta and Lymphadenitis and lymphangitis - a phase IV clinical study of FDA data
Summary:
Lymphadenitis and lymphangitis is reported as a side effect among people who take Venclexta (venetoclax), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Imbruvica, and have High blood pressure.
The phase IV clinical study analyzes which people have Lymphadenitis and lymphangitis when taking Venclexta. It is created by eHealthMe based on reports of 31,417 people who have side effects when taking Venclexta from the FDA, and is updated regularly.
What is Venclexta?
Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.
What is Lymphadenitis and lymphangitis?
Lymphadenitis and lymphangitis (inflammation or an infection of the lymphatic channels and lymph glands) is found to be associated with 84 drugs and 284 conditions by eHealthMe. Check the latest studies of Lymphadenitis and lymphangitis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
31,417 people reported to have side effects when taking Venclexta.
Among them, 14 people (0.04%) have Lymphadenitis and lymphangitis.

Among these 14 people:
How long have people been on Venclexta when they have Lymphadenitis and lymphangitis? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Lymphadenitis and lymphangitis when taking Venclexta? *
- female: 92.86 %
- male: 7.14 %
What is the age of people who have Lymphadenitis and lymphangitis when taking Venclexta? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 7.69 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 92.31 %
What are other drugs people take besides Venclexta? *
- Imbruvica: 12 people, 85.71%
- Valacyclovir: 11 people, 78.57%
- Gazyva: 11 people, 78.57%
- Vitamin B6: 8 people, 57.14%
- Benadryl: 8 people, 57.14%
- Lexapro: 6 people, 42.86%
- Prilosec: 4 people, 28.57%
- Ditropan Xl: 4 people, 28.57%
- Rituxan: 1 person, 7.14%
- Oxycodone: 1 person, 7.14%
What are other side effects people have besides Lymphadenitis and lymphangitis? *
- Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 12 people, 85.71%
- Urinary Tract Infection: 12 people, 85.71%
- Nausea (feeling of having an urge to vomit): 12 people, 85.71%
- Weakness: 12 people, 85.71%
- High Blood Pressure: 12 people, 85.71%
- Cellulitis (infection under the skin): 12 people, 85.71%
- Fatigue (feeling of tiredness): 12 people, 85.71%
- Joint Pain: 12 people, 85.71%
- Hair Loss: 11 people, 78.57%
- Immunodeficiency: 11 people, 78.57%
What are the existing conditions these people have? *
- High Blood Pressure: 12 people, 85.71%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 11 people, 78.57%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 8 people, 57.14%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 50.00%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 35.71%
- Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 28.57%
- Chronic Lymphocytic Leukaemia Transformation (white blood cell cancer changes in fast growing cancer in lymph node): 3 people, 21.43%
- Richter's Syndrome (hairy cell cancer changes in fast growing b cell cancer tumour): 2 people, 14.29%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 14.29%
- Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Venclexta and have Lymphadenitis and lymphangitis?
- Check whether Lymphadenitis and lymphangitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Venclexta:
- Venclexta (31,425 reports)
Lymphadenitis and lymphangitis treatments and more:
- Lymphadenitis and lymphangitis (591 reports)
How severe was Lymphadenitis and lymphangitis and when was it recovered:
Expand to all the drugs that have ingredients of venetoclax:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Venclexta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Lymphadenitis and lymphangitis:
- Lymphadenitis and lymphangitis (84 drugs)
Browse all the conditions that are associated with Lymphadenitis and lymphangitis:
- Lymphadenitis and lymphangitis (284 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on venetoclax (the active ingredients of Venclexta) and Venclexta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Valsartan cause Fatigue Aggravated? - now
- Could Opdivo cause Weight Loss? - a second ago
- Could Valsartan cause Hypocalcaemia? - 11 seconds ago
- Could Ondansetron cause Septic Shock? - 15 seconds ago
- Could Onivyde cause Diarrhea? - 15 seconds ago
- Could Onivyde cause Stools - Watery? - 15 seconds ago
- Atenolol and Tacrolimus drug interactions for men aged 50-59 - 17 seconds ago
- Could Cotrim cause Thrombosis? - 18 seconds ago
- Could Azithromycin cause Sleep Disorder? - 21 seconds ago
- Plan B and Prednisone drug interactions for women aged 20-29 - 21 seconds ago